SCH 39370
Latest Information Update: 22 Jul 1994
Price :
$50 *
At a glance
- Originator Unknown
- Developer Schering-Plough
- Class Antihypertensives
- Mechanism of Action Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure